Long-term outcome after thrombectomy in acute myocardial infarction

European Journal of Clinical Investigation

Volumn 40, Issue 3, 2010, Pages 233-241

  Adlbrecht, C ^a   Distelmaier, K ^a   Bonderman, D ^a   Beran, G ^a   Redwan, B ^a   Strunk, G ^b   Binder, T ^a   Jakowitsch, J ^a   Probst, P ^a   Heinze, G ^a   Maurer, G ^a   Lang, I M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

Author keywords

Acute myocardial infarction; Long term; Re hospitalization; Readmission; Risk; Thrombectomy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; ST SEGMENT ELEVATION; SURVIVAL RATE; THROMBECTOMY;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; RISK; THROMBECTOMY; TREATMENT OUTCOME;

EID: 77649195301     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02253.x     Document Type: Article

References (52)

1. Thatcher JL, Gilseth TA, Adlis S. Improved efficiency in acute myocardial infarction care through commitment to emergency department-initiated primary PCI. J Invasive Cardiol 2003 15 : 693 698.
2. Bonderman D, Teml A, Jakowitsch J, Adlbrecht C, Gyongyosi M, Sperker W et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood 2002 99 : 2794 2800.
3. Adlbrecht C, Bonderman D, Plass C, Jakowitsch J, Beran G, Sperker W et al. Active endothelin is an important vasoconstrictor in acute coronary thrombi. Thromb Haemost 2007 97 : 642 649.
4. Lefevre T, Garcia E, Reimers B, Lang I, di Mario C, Colombo A et al. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol 2005 46 : 246 252.
5. Napodano M, Pasquetto G, Sacca S, Cernetti C, Scarabeo V, Pascotto P et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003 42 : 1395 1402.
6. Burzotta F, Trani C, Romagnoli E, Mazzari MA, Rebuzzi AG, De Vita M et al. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 2005 46 : 371 376.
7. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005 293 : 1063 1072.
8. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AW, Hoorntje JC et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002 23 : 1112 1117.
9. Kaltoft A, Bottcher M, Nielsen SS, Hansen HH, Terkelsen C, Maeng M et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation. 2006 114 : 40 7. Epub 2006 Jun 26.
10. Sardella G, Mancone M, Nguyen BL, De Luca L, Di Roma A, Colantonio R et al. The effect of thrombectomy on myocardial blush in primary angioplasty: the randomized evaluation of thrombus aspiration by two thrombectomy devices in acute myocardial infarction (RETAMI) trial. Catheter Cardiovasc Interv 2008 71 : 84 91.
11. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008 358 : 557 567.
12. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann FJ, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 2007 153 : 343 353.
13. Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008 371 : 1915 1920.
14. Sharma SK, Tamburrino F, Mares AM, Kini AS. Improved outcome with angiojet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus. J Invasive Cardiol 2006 18 (Suppl. C 8C 11C.
15. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000 83 : 596 602.
16. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002 4 : 361 371.
17. Beran G, Lang I, Schreiber W, Denk S, Stefenelli T, Syeda B et al. Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation 2002 105 : 2355 2360.
18. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007 28 : 2525 2538. (Pubitemid 47616190)
19. Greene HL, Richardson DW, Barker AH, Roden DM, Capone RJ, Echt DS et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989 63 : 1 6.
20. Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O et al. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 2007 13 : 120 127.
21. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 2004 10 : 328 333.
22. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003 89 : 1303 1307.
23. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003 107 : 1486 1491. (Pubitemid 36378485)
24. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol 1997 29 : 1060 1066.
25. Altieri P, Brunelli C, Garibaldi S, Nicolino A, Ubaldi S, Spallarossa P et al. Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur J Clin Invest 2003 33 : 648 656.
26. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 : 457 481.
27. Cox D. Regression models and life tables. JR Stat Soc B 1972 34 : 187 220.
28. Lin D, Wei L. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989 84 : 1074 1078.
29. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006 354 : 2473 2483.
30. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J 2008 29 : 2989 3001.
31. De Vita M, Burzotta F, Biondi-Zoccai GG, Lefevre T, Dudek D, Antoniucci D et al. Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: A pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data. Vasc Health Risk Manag 2009 5 : 243 247.
32. Steg PG, Ducrocq G. Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly. Eur Heart J 2008 29 : 2953 2954.
33. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001 88 : 530 533.
34. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006 367 : 356 367.
35. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995 92 : 1117 1125.
36. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996 93 : 223 228.
37. Ahmed A, Zile MR, Rich MW, Fleg JL, Adams KF Jr., Love TE et al. Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure. Am J Cardiol 2007 99 : 460 464.
38. Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab 2007 17 : 17.
39. Tsujino T, Kawasaki D, Masuyama T. Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications. Am J Cardiovasc Drugs 2006 6 : 219 230.
40. Kondo H, Suzuki T, Fukutomi T, Suzuki S, Hayase M, Ito S et al. Effects of percutaneous coronary arterial thrombectomy during acute myocardial infarction on left ventricular remodeling. Am J Cardiol 2004 93 : 527 531. (Pubitemid 38293052)
41. De Luca L, Sardella G, Davidson CJ, De Persio G, Beraldi M, Tommasone T et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart. 2006 92 : 951 957. Epub 2005 Oct 26.
42. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006 367 : 113 121.
43. Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006 47 : 332 337.
44. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998 97 : 1921 1929.
45. Tziakas DN, Chalikias GK, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris A et al. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction. Am J Cardiol 2005 96 : 31 4.
46. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003 41 : 2010 2017. (Pubitemid 36677124)
47. Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T et al. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 2005 128 : 21 9.
48. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004 110 : 3206 3212.
49. Lankeit M, Dellas C, Panzenbock A, Skoro-Sajer N, Bonderman D, Olschewski M et al. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2008 6 : 6.
50. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999 99 : 3063 3070.
51. Formigli L, Perna AM, Meacci E, Cinci L, Margheri M, Nistri S et al. Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling. J Cell Mol Med 2007 11 : 1087 1100.
52. Abdel-Wahab M, El-Shahed G, Awadalla H, Amin M, El-Hammady W, Ayoub A. Relationship between systolic pulsed wave tissue Doppler parameters and both invasive and noninvasive reperfusion criteria in patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention. J Am Soc Echocardiogr 2008 21 : 47 52.